Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus

Neuroscience Letters

Volumn 571, Issue , 2014, Pages 11-16

  Koga, Shunsuke ^b   Kojima, Ayako ^a   Kuwabara, Satoshi ^b   Yoshiyama, Yasumasa ^a,b  

^a SAKURA NATIONAL HOSPITAL   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer disease; Astrocyte; Diet induced obesity; Tau phosphorylation; Voluntary exercise; Wild type mouse

Indexed keywords

AMYLOID BETA PROTEIN; LEPTIN RECEPTOR; TAU PROTEIN; FAT INTAKE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; EXERCISE; FEMALE; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MACROGLIA; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; ASTROCYTE; FAT INTAKE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; WEIGHT GAIN;

ANIMALS; ASTROCYTES; DIETARY FATS; FEMALE; GLIOSIS; HIPPOCAMPUS; MICE; OBESITY; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, LEPTIN; TAU PROTEINS; WEIGHT GAIN;

EID: 84899826728     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.04.028     Document Type: Article

References (23)

1. Akiyama H., Arai T., Kondo H., Tanno E., Haga C., Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 2000, 14:47-53.
2. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42:631-639.
3. Augustinack J.C., Schneider A., Mandelkow E.M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 2002, 103:26-35.
4. Bhat N.R., Thirumangalakudi L. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. J. Alzheimers Dis. 2013, 36:781-789.
5. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M., Alzheimer's Disease International Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
6. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., Luchsinger J.A. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 2009, 66:336-342.
7. Fuente-Martín E., García-Cáceres C., Granado M., de Ceballos M.L., Sánchez-Garrido M.Á., Sarman B., Liu Z.W., Dietrich M.O., Tena-Sempere M., Argente-Arizón P., Díaz F., Argente J., Horvath T.L., Chowen J.A. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J. Clin. Invest. 2012, 122:3900-3913.
8. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
9. Hsuchou H., He Y., Kastin A.J., Tu H., Markadakis E.N., Rogers R.C., Fossier P.B., Pan W. Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain 2009, 132:889-902.
10. Jayaram B., Pan W., Wang Y., Hsuchou H., Mace A., Cornelissen-Guillaume C.G., Mishra P.K., Koza R.A., Kastin A.J. Astrocytic leptin-receptor knockout mice show partial rescue of leptin resistance in diet-induced obesity. J. Appl. Physiol. 2013, 114:734-741.
11. Jeon B.T., Jeong E.A., Shin H.J., Lee Y., Lee D.H., Kim H.J., Kang S.S., Cho G.J., Choi W.S., Roh G.S. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61:1444-1454.
12. Leboucher A., Laurent C., Fernandez-Gomez F.J., Burnouf S., Troquier L., Eddarkaoui S., Demeyer D., Caillierez R., Zommer N., Vallez E., Bantubungi K., Breton C., Pigny P., Buée-Scherrer V., Staels B., Hamdane M., Tailleux A., Buée L., Blum D. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes 2013, 62:1681-1688.
13. Leung J.C., Chan L.Y., Lam M.F., Tang S.C., Chow C.W., Lim A.I., Lai K.N. The role of leptin and its short-form receptor in inflammation in db/db mice infused with peritoneal dialysis fluid. Nephrol. Dial. Transplant. 2012, 27:3119-3129.
14. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Asada M., Watanabe K., Hayashida N., Ihara M., Ito H., Shimohama S., Kihara T., Kinoshita A. Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice. Neurobiol. Aging 2012, 33. 1011.e11-23.
15. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Hayashida N., Asada-Utsugi M., Watanabe K., Uemura M., Kihara T., Takahashi R., Shimohama S., Kinoshita A. Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J. Biol. Chem. 2012, 287:23024-23033.
16. Moroz N., Tong M., Longato L., Xu H., de la S.M. Monte; Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 2008, 15:29-44.
17. Profenno L.A., Porsteinsson A.P., Faraone S.V. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol. Psychiatry 2010, 67:505-512.
18. Su J.H., Cummings B.J., Cotman C.W. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neuritis. Neuroreport 1994, 17:2358-2362.
19. Togo T., Dickson D.W. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol. 2002, 104:398-402.
20. Whitmer R.A. The epidemiology of adiposity and dementia. Curr. Alzheimer Res. 2007, 4:117-122.
21. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
22. Yoshiyama Y., Kojima A., Ishikawa C., Arai K. Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J. Alzheimers Dis. 2010, 22:295-306.
23. Yoshiyama Y., Kojima A., Itoh K., Uchiyama T., Arai K. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model. Neurobiol. Dis. 2012, 45:329-336.